| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0169-409X(01)00244-7 |
| P698 | PubMed publication ID | 11755708 |
| P50 | author | Thomas Kissel | Q79185479 |
| P2093 | author name string | Florian Unger | |
| Youxin Li | |||
| P2860 | cites work | Protein instability in poly(lactic-co-glycolic acid) microparticles. | Q30327666 |
| Optimization of preparative conditions for poly-DL-lactide- polyethylene glycol microspheres with entrapped Vibrio cholera antigens | Q30559079 | ||
| Protein release from physically crosslinked hydrogels of the PLA/PEO/PLA triblock copolymer-type. | Q30632670 | ||
| Protein spray-freeze drying. Effect of atomization conditions on particle size and stability | Q30980930 | ||
| The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices | Q34072262 | ||
| Poly-DL-lactic acid: polyethylene glycol block copolymers. The influence of polyethylene glycol on the degradation of poly-DL-lactic acid | Q36734926 | ||
| Drug delivery systems and routes of administration of peptide and protein drugs | Q37946841 | ||
| Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues | Q38548963 | ||
| Biocompatibility testing of ABA triblock copolymers consisting of poly(L-lactic-co-glycolic acid) A blocks attached to a central poly(ethylene oxide) B block under in vitro conditions using different L929 mouse fibroblasts cell culture models | Q38549166 | ||
| Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties. | Q38549181 | ||
| Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition | Q38549321 | ||
| Monitoring microviscosity and microacidity of the albumin microenvironment inside degrading microparticles from poly(lactide-co-glycolide) (PLG) or ABA-triblock polymers containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly | Q38551596 | ||
| Morphological study of biodegradable PEO/PLA block copolymers | Q38592805 | ||
| Biodegradable PELA block copolymers: in vitro degradation and tissue reaction | Q38596027 | ||
| Compositional and structural analysis of PELA biodegradable block copolymers degrading under in vitro conditions | Q39044762 | ||
| New long-acting injectable microcapsule contraceptive system | Q39686685 | ||
| Biodegradation of PLA/GA polymers: increasing complexity | Q40498395 | ||
| Cellular uptake of PEO surface-modified nanoparticles: evaluation of nanoparticles made of PLA:PEO diblock and triblock copolymers | Q40862346 | ||
| The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. | Q42011060 | ||
| Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres | Q44842072 | ||
| Degradation and protein release properties of microspheres prepared from biodegradable poly(lactide-co-glycolide) and ABA triblock copolymers: influence of buffer media on polymer erosion and bovine serum albumin release | Q45021754 | ||
| Sustained suppression of pituitary-gonadal axis with an injectable, in situ forming implant of leuprolide acetate | Q45301017 | ||
| Morphological characterization of microspheres, films and implants prepared from poly(lactide-co-glycolide) and ABA triblock copolymers: is the erosion controlled by degradation, swelling or diffusion? | Q45328211 | ||
| A biodegradable polymer as a cytokine delivery system for inducing bone formation. | Q45972847 | ||
| Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence | Q47358427 | ||
| Poly(ethylene oxide) (PEO) and different molecular weight PEO blends monolithic devices for drug release | Q47400517 | ||
| Microdomain structure in polylactide-block-poly(ethylene oxide) copolymer films. | Q53917406 | ||
| Investigation on process parameters involved in preparation of poly-DL-lactide-poly(ethylene glycol) microspheres containing Leptospira Interrogans antigens. | Q53933910 | ||
| The degradation, swelling and erosion properties of biodegradable implants prepared by extrusion or compression moulding of poly(lactide-co-glycolide) and ABA triblock copolymers | Q57188789 | ||
| Hydrolytic degradation of PLA/PEO/PLA triblock copolymers prepared in the presence of Zn metal or CaH2 | Q59307358 | ||
| Structure-property relationships in the case of the degradation of massive aliphatic poly-(?-hydroxy acids) in aqueous media | Q59307414 | ||
| Polymer-Polymer Phase Behavior | Q60163958 | ||
| Hydrogels for controlled drug delivery | Q70945015 | ||
| The release of 5-fluorouracil from a swellable matrix of a triblock copolymer of epsilon-caprolactone and ethylene oxide | Q70980674 | ||
| In vivo biocompatibility study of ABA triblock copolymers consisting of poly(L-lactic-co-glycolic acid) A blocks attached to central poly(oxyethylene) B blocks | Q71488945 | ||
| Protein stability in controlled-release systems | Q73333850 | ||
| Branched biodegradable polyesters for parenteral drug delivery systems | Q73367993 | ||
| Stabilization of proteins encapsulated in cylindrical poly(lactide-co-glycolide) implants: mechanism of stabilization by basic additives | Q73761311 | ||
| In vitro protein release and degradation of poly-dl-lactide-poly(ethylene glycol) microspheres with entrapped human serum albumin: quantitative evaluation of the factors involved in protein release phases | Q73834506 | ||
| One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate | Q73850243 | ||
| Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives | Q74830492 | ||
| Biodegradable microspheres containing influenza A vaccine: immune response in mice | Q77296829 | ||
| Polymeric systems for controlled drug release | Q77367258 | ||
| Biodegradable recombinant human erythropoietin loaded microspheres prepared from linear and star-branched block copolymers: influence of encapsulation technique and polymer composition on particle characteristics | Q77760323 | ||
| New synthetic absorbable polymers as BMP carriers: plastic properties of poly-D,L-lactic acid-polyethylene glycol block copolymers | Q77986095 | ||
| Preparation of nanoparticles consisted of poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) and their evaluation in vitro | Q78056751 | ||
| Freeze-drying and lyopreservation of diblock and triblock poly(lactic acid)-poly(ethylene oxide) (PLA-PEO) copolymer nanoparticles | Q93944406 | ||
| Development of biodegradable polymeric paste formulations for taxol: An in vitro and in vivo study | Q105213680 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biodegradation | Q696715 |
| hydrogel | Q898925 | ||
| P304 | page(s) | 99-134 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Advanced Drug Delivery Reviews | Q2825362 |
| P1476 | title | ABA-triblock copolymers from biodegradable polyester A-blocks and hydrophilic poly(ethylene oxide) B-blocks as a candidate for in situ forming hydrogel delivery systems for proteins | |
| P478 | volume | 54 |
| Q33647418 | 5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice |
| Q57347121 | A Thermoresponsive Hydrogel Formed from a Star-Star Supramolecular Architecture |
| Q57366343 | A glucosyl triblock copolymer: synthesis and its injectable thermo- and pH-responsive behaviours |
| Q38303629 | Aptamer-gelatin composite for a trigger release system mediated by oligonucleotide hybridization |
| Q35134480 | Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility |
| Q31148504 | Biodegradable hydrophobic-hydrophilic hybrid hydrogels: swelling behavior and controlled drug release |
| Q57381746 | Biodegradable polymeric nanocarriers for pulmonary drug delivery |
| Q37002674 | Biodegradable polymers for microencapsulation of drugs. |
| Q38086377 | Concepts and practices used to develop functional PLGA-based nanoparticulate systems |
| Q56978527 | Controlling surface properties and permeability of polyglycerol network films |
| Q37946820 | Copolymers: efficient carriers for intelligent nanoparticulate drug targeting and gene therapy. |
| Q33902253 | Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release. |
| Q56979429 | Degradation Behavior of Porous Copolyester Microparticles in the Light of Dynamic Changes in Their Morphology |
| Q37814131 | Differential scanning calorimetry techniques: applications in biology and nanoscience |
| Q85928399 | Effects of bevacizumab loaded PEG-PCL-PEG hydrogel intracameral application on intraocular pressure after glaucoma filtration surgery |
| Q39358580 | Efficient inhibition of colorectal peritoneal carcinomatosis by drug loaded micelles in thermosensitive hydrogel composites |
| Q37360922 | Encapsulation of protein nanoparticles into uniform-sized microspheres formed in a spinning oil film. |
| Q39115464 | Facile Synthesis of PEGylated PLGA Nanoparticles Encapsulating Doxorubicin and its In Vitro Evaluation as Potent Drug Delivery Vehicle. |
| Q42818952 | Gelatin hydrogels: enhanced biocompatibility, drug release and cell viability |
| Q53195809 | Hydrolytic degradation behavior of poly(rac-lactide)-block-poly(propylene glycol)-block-poly(rac-lactide) dimethacrylate derived networks designed for biomedical applications. |
| Q33408379 | In vitro drug release behavior from a novel thermosensitive composite hydrogel based on Pluronic f127 and poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) copolymer |
| Q39597762 | Investigation on injectable, thermally and physically gelable poly(ethylene glycol)/poly(octadecanedioic anhydride) amphiphilic triblock co-polymer nanoparticles. |
| Q41969058 | Lysozyme release and polymer erosion behavior of injectable implants prepared from PLGA-PEG block copolymers and PLGA/PLGA-PEG blends |
| Q34793080 | Melt extrusion: from process to drug delivery technology |
| Q34185709 | Microencapsulation: A promising technique for controlled drug delivery |
| Q44295255 | Phase separation and physical properties of PEO-containing poly(ether ester amide)s |
| Q46931311 | Photo-cross-linkable and thermo-responsive hydrogels containing chitosan and Pluronic for sustained release of human growth hormone (hGH). |
| Q34609827 | Photo-cross-linked PLA-PEO-PLA hydrogels from self-assembled physical networks: mechanical properties and influence of assumed constitutive relationships |
| Q43735438 | Poly(D,L-lactide-co-ethyl ethylene phosphate)s as new drug carriers |
| Q35044554 | Poly-D,L-lactide-co-poly(ethylene glycol) microspheres as potential vaccine delivery systems |
| Q59124929 | Polylactic Acid Based Nanocomposites: Promising Safe and Biodegradable Materials in Biomedical Field |
| Q37065943 | Polymer-based sustained-release dosage forms for protein drugs, challenges, and recent advances |
| Q46449945 | Preparation and investigation of a novel levobupivacaine in situ implant gel for prolonged local anesthetics |
| Q41988316 | Preparation and investigation of sustained drug delivery systems using an injectable, thermosensitive, in situ forming hydrogel composed of PLGA-PEG-PLGA. |
| Q35579383 | Recent Developments in Ring Opening Polymerization of Lactones for Biomedical Applications |
| Q57367351 | Sol–gel transition of PEG–PAF aqueous solution and its application for hGH sustained release |
| Q43069368 | Stability of proteins encapsulated in injectable and biodegradable poly(lactide-co-glycolide)-glucose millicylinders |
| Q92948035 | Sustained Release of Vascular Endothelial Growth Factor from Poly(ε-caprolactone-PEG-ε-caprolactone)-b-Poly(l-lactide) Multiblock Copolymer Microspheres |
| Q42843255 | Tacticity Control in the Synthesis of Poly(lactic acid) Polymer Stars with Dipentaerythritol Cores |
| Q51810322 | Tailoring mechanical response through coronal layer overlap in tethered micelle hydrogel networks. |
| Q33569881 | The PEG-PCL-PEG Hydrogel as an Implanted Ophthalmic Delivery System after Glaucoma Filtration Surgery; a Pilot Study |
| Q46515239 | Thermodynamic compatibility of actives encapsulated into PEG-PLA nanoparticles: In Silico predictions and experimental verification |
| Q38979496 | Tumor regression achieved by encapsulating a moderately soluble drug into a polymeric thermogel |
| Q90953694 | Vascular Endothelial Growth Factor-Releasing Microspheres Based on Poly(ε-Caprolactone-PEG-ε-Caprolactone)-b-Poly(L-Lactide) Multiblock Copolymers Incorporated in a Three-Dimensional Printed Poly(Dimethylsiloxane) Cell Macroencapsulation Device |
Search more.